10.10.24|James SpiroThe company took part in CTech’s Startup Boarding Pass series to share how its technology will change lung function testing for millions of Americans.
09.10.24|Dr. Debbie Anaby, Prof. Miri Sklair-Levy"The future of AI in medicine is only at its beginning. The digital revolution is no longer a futuristic dream—it is happening now," write Professor Miri Sklair-Levy and Dr. Debbie Anaby.
10.09.24|Sophie ShulmanThe startup has launched the CanvOI model, powered by Oracle Cloud, to advance cancer treatment.
14.06.24|Elihay VidalOur AI-generated hosts talk through some of tech's biggest stories this week
09.06.24|Ariela KarmelNew Phase CEO Ofer Shalev spoke to CTech about their technology which turns advanced cancer into a chronic ailment, extending the lifespans and treating symptoms without any of the side effects associated with other existing treatments
19.12.23|Sophie ShulmanThe Israeli company utilizes its broadly applicable predictive computational discovery capabilities to identify new drug targets and biological pathways for developing novel cancer immunotherapies
06.09.23|Meir OrbachThe Israeli startup’s platform provides health systems and diagnostic laboratories with an integrated solution for cancer diagnosis and biomarker scoring, capable of detecting more than 100 different cancer and non-cancer pathologies
30.11.22|Meir OrbachThe Israeli company is aiming to achieve new standards for efficacy and patient response across a number of difficult-to-treat cancers
01.09.22|Itay Barnea“The treating physician should determine what is best for the patient based on his unique age, family history, health, lifestyle, race, ethnic background, and other factors,” writes Itay Barnea, CEO of BioProtect
30.08.22|Ofer SharonIsrael can become a precision oncology powerhouse, but we need to change direction, writes Dr. Ofer Sharon, CEO of OncoHost
23.06.22|CTechEach type of cancer has a unique odor, and most also have a common denominator. Dogs can detect these odors in a fraction of a second
02.05.22|Meir OrbachUsing only a digitized biopsy image, the Israeli startup’s diagnostic technology delivers real-time molecular analysis, increasing the level of accuracy and reducing the time required for results, from several weeks to just two minutes
16.04.22|Diana Bahur-NirAfter beating multiple cancers, former Chief Scientist Orna Berry turned being a cancer survivor into a hobby
05.01.22|Meir OrbachThe Israeli company develops non-invasive, DNA methylation-based cancer screening tests for early-stage and recurring cancer detection
26.12.21|CTechThe drug, developed in Israel by Ayana Pharma, will be tested under zero-gravity conditions after being launched last week in a smart laboratory belonging to Israeli company SpacePharma aboard Elon Musk's Falcon 9 launcher
16.06.21|James SpiroThe round will be used to advance the clinical development of KAHR’s lead product candidate, DSP107
09.06.21|James SpiroThe U.S Food and Drug Administration formally acknowledged its Galen platform and the potential benefit it has on American patients
26.05.21|James SpiroThe Ibex Galen Breast solution can detect multiple types of breast cancer and provide accurate diagnoses
04.04.21|Hezi SternlichtThe decision puts the company’s tumor-freezing technology on the fast track for final approval
09.03.21|Meir OrbachIbex’s solutions detect cancer in real-time, enabling 100% quality control, while also reducing turnaround times